期刊文献+

蛋白尿加重糖尿病肾病血液高凝状态的临床研究 被引量:7

Proteinuria Aggravate Hypercoagulation in Patients with Diabetic Nephropathy
暂未订购
导出
摘要 目的 :探讨糖尿病肾病患者血液高凝状态与蛋白尿的关系。方法 :5 7例糖尿病肾病患者 ,以 2 4h尿蛋白定量分为高 (H)、中 (M )和低 (L)三组。并对其中 17例实施 8个月的华法令治疗。系统检测凝血、纤溶及肾功能指标。结果 :伴随尿蛋白量增多 ,凝血活性进一步亢进 ;但华法令改善高凝状态后 ,尿蛋白并无改善。结论 :血液高凝状态伴随糖尿病肾病患者蛋白尿出现而形成 ,并因此逐渐加重。 Objective:To investigate the relationship of hypercoagulation and proteinuria in patients with diabetic nephropathy(DN).Methods:Fifty-seven patients definitely diagnosed as diabetes type Ⅱ, DN participated in the study. According to 24 h urinary protein, they were divided into 3 groups including 16 cases as L group, 17 cases as M group; 24 cases as H group. 17 cases of 57 patients were received warfarin therapy. Detecting the parameter of coagulation and fibrolysis with ELISA as well as urinary protein and renal function.Results:Patients with major urinary protein (H group) appeared more activities of coagulation than that with moderate and mild renal dysfunction (L group and M group). Warfarin could obviously improve the state of hypercoagulation, but did not decreased urinaru protein in patients with DN.Conclusion:The proteinuria not only results in hypercoagulation,but also aggravates the hypercoagulable state in patients with DN.
出处 《中国中西医结合肾病杂志》 2002年第6期326-328,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 血液 临床研究 高凝状态 糖尿病肾病 蛋白尿 相关性 Hypercoagulation Diabetic nephropathy Proteinuria
  • 相关文献

参考文献9

  • 1清水弘行 根岸真由美 大谷键一 等.糖尿病性ァルブミン尿症例にあける血中トロンビン—アンチトロンビンⅢ复合体浓度の增加[J].糖尿病,1996,39(2):147-151.
  • 2Myrup B, Rossing P, Jensen T, et al. Procoagulant activity and intimal dysfunction in IDDM. Diabetologia, 1995, 38(1):73-78
  • 3和田英夫 板根祥裕.血栓症:诊断と治疗の进步.Ⅱ血栓症の诊断へのアプロ—チ.血栓症早期诊断のための临床检查[J].日内会志,1997,86(6):911-914.
  • 4由井克昌 田中明 诸星政治 等.糖尿病患者血中トロンボモヅェリン检讨——血清ケレアチン值による补正の试み[J].糖尿病,1994,37(10):726-730.
  • 5孙雪峰,周希静,严海东,王力宁.血液高凝状态加重糖尿病肾病肾功能障碍[J].中华血液学杂志,2001,22(9):476-477. 被引量:24
  • 6Vogt B W. -Amino-lysine-bound glucose in human tissues obtained at autopsy: Increase in diabetes mellitus. Diabetes, 1982,31:1123.
  • 7Shimomura H, Spiro RG. Studies on macromolecular components of human glomerular basement membrance and alterations in diabetes. -Decreased levels of heparan sulfate proteoglycan and laminin. Diabetes, 1987,36:374.
  • 8矶贝行秀.糖尿病と血管障碍——その成因をめぐつて[J].Diabetes Frontier,1997,8:16-24.
  • 9森下真理子 松田保.糖尿病にみる凝固*纤溶の异常[J].Diabetes Frontier,1997,8:29-32.

二级参考文献1

  • 1Dr. B. Myrup,P. Rossing,T. Jensen,J. Gram,C. Kluft,J. Jespersen. Procoagulant activity and intimal dysfunction in IDDM[J] 1995,Diabetologia(1):73~78

共引文献27

同被引文献53

  • 1田浩明 梁荩忠.糖尿病人血脂监测及其临床应用[J].实用糖尿病杂志,1995,3:426-426.
  • 2[2]Boemi M,Sirolla C,Fumelli P. Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients.Diabetes Care,1999,22(12):2033-2036.
  • 3[3]Nakagawa H,Kida Y.Relationship between the stage of diabetic nephropathy and serum lipoprotein(a) concentrations-influence of hypoproteinemia. Nippon Jinzo Gakkai Shi,1996,38(11):513-518.
  • 4[4]Kronenberg F, Trenkwalder E,Lingenhel A, et al. Renovascular arteriovenous differences in Lp(a) plasma concentrations suggest removal of Lp(a) from the renal circulation. J Lipid Res, 1997, 38(9):1755-1763.
  • 5[8]Nogaki F, Muso E, Yashiro M, et al. Direct inhibitory of simvastatin on matrix accumulation in cultured murine mesangial cells.Kidney Int,1999,71(Suppl):198-201.
  • 6Kelly DE,Williams KV,Price JC,et al.Plasma fatty acids,adiposity,and variance of skeletal muscle in sulin resistance in type2 diabetes mellitus[J].Clin Endocrinol Metab,2001,86(11):5412.
  • 7Robles NR,Ruiz Calero R,Coronado M,et al.Treatment with pravatatin of dyslipidemia associated with diabetic Nephropathy[J].An Med Interna,1998,15(11):572-575.
  • 8Massy ZA,Kim Y,Guijarro C,et al.Low density lipoprotein induced expression of interleukin 6,marker of human mesangial cell inflammation:effects of oxidation and modulation by lovastatin[J].Biochem Biophys Res Commun,2000,267(8):536-540.
  • 9Marre M,Bernade,Gallosis Y,et al.Relationships between angiotensin Ⅰ converting enzyme gene polymorphism,plasma levels and diabetic retinal and renal complication[J].Diabetes,1994,43(3):384-387.
  • 10Trenkwalder E,Gruber A,Konig P,et al.Increased plasma concen tration of LDL-unbound apo(a) in patients with end stage disease[J].Kidney Iht,1997,52(6):1685-1692.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部